bms204352 and ibuprofen
bms204352 has been researched along with ibuprofen in 3 studies
Compound Research Comparison
Studies (bms204352) | Trials (bms204352) | Recent Studies (post-2010) (bms204352) | Studies (ibuprofen) | Trials (ibuprofen) | Recent Studies (post-2010) (ibuprofen) |
---|---|---|---|---|---|
49 | 1 | 12 | 10,245 | 1,781 | 4,267 |
Protein Interaction Comparison
Protein | Taxonomy | bms204352 (IC50) | ibuprofen (IC50) |
---|---|---|---|
Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 2.9 | |
Prostaglandin G/H synthase 2 | Bos taurus (cattle) | 1.1 | |
Albumin | Bos taurus (cattle) | 3 | |
Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 4.0919 | |
Prostaglandin G/H synthase 1 | Mus musculus (house mouse) | 0.22 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 1.6273 | |
Caspase-1 | Homo sapiens (human) | 7.2667 | |
Substance-P receptor | Cavia porcellus (domestic guinea pig) | 1.1 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 3.0687 | |
Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 1.3 | |
Aldo-keto reductase family 1 member C3 | Homo sapiens (human) | 10 | |
Caspase-3 | Homo sapiens (human) | 7.2667 | |
Caspase-4 | Homo sapiens (human) | 7.2667 | |
4-aminobutyrate aminotransferase, mitochondrial | Rattus norvegicus (Norway rat) | 1.1 | |
Caspase-5 | Homo sapiens (human) | 7.2667 | |
Caspase-9 | Homo sapiens (human) | 7.2667 | |
Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 1.1375 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 2.9 | |
Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 5 | |
Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.54 | |
Solute carrier family 22 member 6 | Homo sapiens (human) | 8 | |
Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 1.3 |
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Reviews
1 review(s) available for bms204352 and ibuprofen
Article | Year |
---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
Other Studies
2 other study(ies) available for bms204352 and ibuprofen
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |